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The Effects of Focus on Performance: Evidence 
from California Hospitals 
 
 
We use hospital level discharge data from cardiac patients in California to estimate the effects of 
focus on operational performance.  We examine focus at three distinct levels of the organization 
– at the firm level, at the operating unit level, and at the process flow level.  We find that focus at 
each of these levels is associated with improved outcomes, namely faster services at higher le-
vels of quality, as indicated by lower lengths of stay (LOS) and reduced mortality rates.  We then 
analyze the extent to which the superior operational outcome is driven by focused hospitals truly 
excelling in their operations or by focused hospitals simply “cherry-picking” easy-to-treat pa-
tients. To do this, we use an instrumental variables estimation strategy that effectively randomiz-
es the assignment of patients to hospitals. After controlling for selective patient admissions, the 
previously observed benefits of firm-level focus disappear; focused hospitals no longer demon-
strate a statistically significant reduction in LOS or mortality rate. However, at more granular 
measures of focus within the hospital (e.g. operating unit level), we find that more focus leads to 
a shorter LOS, even after controlling for selective admission effects. 
 
1.  Introduction 
In his seminal paper, Skinner (1974) states that the “focused factory will out-produce, undersell, 
and quickly gain competitive edge over the complex factory.”  Numerous examples of successful 
focus factories serve to support Skinner’s claim.  For example, Motel 6, a low-budget inn and 
Southwest Airlines, a national US carrier are both successful focused operations that cater to the 
group of budget-conscious travelers.  Likewise, Federal Express has built a lucrative business 
around focusing on providing courier services to customers seeking guaranteed overnight deli-
very.  In healthcare delivery, Shouldice Hospital, a Canadian facility that specializes in inguinal 
hernia repair procedures has an unusually high rate of success (Heskett 1983).  Herzlinger (1997) 
views focus as one of the key sources towards achieving the much needed efficiency improve-
ment in the healthcare industry, and describes numerous opportunities for hospitals to focus their 
operations. Herzlinger’s argument in favor of focused operations has been widely discussed in 
the business press (e.g., see The Economist July 2009) and discussions relating to focused hos-
pitals have played an important role in the ongoing debate on healthcare reform in the US (Time 
July 2009). 
Electronic copy available at: http://ssrn.com/abstract=1815529
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Despite anecdotal accounts of thriving focused factories, few studies have empirically esti-
mated the operational benefits of focus and even fewer studies have sought to identify the under-
lying sources of focus-based efficiency improvements. Why are focused factories better than 
non-focused factories? Are they truly superior in their operations, or is their superior perfor-
mance a result of them cherry-picking an attractive product line at the expense of other factories, 
competition, or society? These are the central research questions of our work. 
To answer these questions, we study the market for cardiac care delivery in California using 
patient level data of 500,437 patients treated in a variety of hospitals. We distinguish between 
three levels of focus – firm level focus, operating unit level focus and process level focus. Our 
definition of firm level focus is the hospital’s focus on cardiac care.  This is simply the percen-
tage of patients admitted primarily for cardiology reasons. Our definition of operating unit level 
focus is the cardiology department’s focus on a specific set of patients.  We choose to examine 
the cardiology department’s focus on patients undergoing coronary revascularization proce-
dures
1
, one of the most common cardiac procedures.  The operating unit level of focus is thus 
defined to be the percentage of patients admitted to the hospital’s cardiology department who 
undergo a coronary revascularization procedure.  Our most granular level of focus takes place at 
the process level and is based on the specific flow path and care process of a patient. In our anal-
ysis, we define the process level focus to be the percentage of cardiac revascularization patients 
who undergo a cardiovascular artery grafting (CABG) procedure. 
Focused hospitals can derive improved outcomes from both superior service delivery and 
from cherry-picking their patients (i.e. selectively admitting easy-to-treat patients).  To disentan-
gle these two effects, we use an instrumental variables (IV) estimation strategy. The levels of 
focus in the set of hospitals that happen to be located close to a patient’s home is not likely to be 
correlated with any medical characteristics of the patient, but is known to have some influence 
on the likelihood with which the patient chooses a focused hospital for his cardiac procedure.  
Our sample includes patients who were assigned to a focused hospital not only because of their 
medical conditions, but also because of their close proximity to one.  In other words, the expla-
natory power of the relative travel distances to predict patient-hospital assignment provides a qu-
asi natural experiment and thereby mimics a random patient-to-hospital assignment. 
                         
1 A candidate for coronary revascularization has varying degrees of blockage in one or more of the vessels that 
supply oxygenated blood to the heart muscle.  Coronary revascularization involves bypassing blockages or removing 
obstructions in the clogged arteries to restore blood flow to the heart muscle.  
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Our theoretical framework with its three levels of focus and our instrumental variable estima-
tion strategy allow us to make the following four contributions. First, we estimate the benefits of 
focus at the firm level by comparing hospitals that have a larger percentage of their patients ad-
mitted in cardiology (focused hospitals) with hospitals having a lower percentage of total cardiac 
patients (non-focused hospitals).  We find that an increase in focus by 10% is associated with a 
reduction in length of stay by 3.88%; for the average patient, a 0.l unit increase in focus corres-
ponds to a percentage reduction in mortality by a factor of 2.1%.  Second, we show that these 
benefits of focus continue to be occur as we move from the firm or hospital level (percentage of 
patients admitted to cardiology) to the operating unit or cardiac department level (percentage of 
patients in cardiology that require a revascularization procedure) and ultimately to the process 
flow level (percentage of revascularization patients who undergo a CABG).  Specifically, we 
find that at the operating unit level an increase in focus by 10% is associated with a greater re-
duction in length of stay by 4.92%.  For the average patient, a 0.l unit increase in operating unit 
focus corresponds to a percentage reduction in mortality by a factor of 1.5%.  In addition, a 0.1 
unit increase in process level focus is associated with a percentage reduction in mortality rate by 
5.6%.  Third, we compare the pre-operative risk levels across focused and non-focused hospitals 
and show that cardiology patients admitted to focused hospitals have a significantly lower pre-
operative risk score. This is consistent with the hypothesis that focused hospitals cherry-pick 
their patients.  Fourth, once we adjust for the selective admissions using our IV estimator, we 
find that at the firm (or hospital) level, focus does not lead to a statistically improved length of 
stay (LOS) or mortality.  However, in examining operating unit focus, we find that cardiology 
departments that focus on revascularization procedures achieve a shorter LOS and similar levels 
of mortality risk (controlling for the fact that they admit less risky patients).   
Our findings lead to several managerial and policy implications. From the perspective of a 
profit-seeking enterprise, focus is an attractive strategy to pursue. A profit maximizer does not 
need to worry about the sources of the improved operational performance; it is the result that 
counts. From a societal perspective, the benefits of focused hospitals are much smaller than what 
was previously believed. Cherry-picking of easy-to-treat patients is not illegal, unless the refer-
ring physician has a financial stake in the hospital where the patient is sent (see Iglehart 2005 for 
a discussion). In fact, a division of labor in which some hospitals deal with easy-to-treat patients 
while others treat high risk patients with relatively rare medical conditions might even be in the 
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interest of social welfare. Yet, this requires an adjustment of hospital reimbursement practices, 
such as an increase in payments made to general service hospitals, who may deal with riskier pa-
tients requiring more costly service.  Finally, our results also suggest that in order to achieve real 
operational improvement beyond cherry-picking, a focused factory strategy needs to be imple-
mented at the operational level rather than at the firm level.  
2.  Literature 
The idea of focus in operations goes back to Skinner’s (1974) claim that the focused factory 
“does a better job because repetition and concentration in one area allows its workforce to be 
more effective.”  Subsequent research has studied the implications of focus in various industries.  
McLaughlin et al (1995) explore attributes of professional service firms for which a focused 
strategy is effective.  They identify customer group selection and operating process as separate 
focus service strategies in professional service delivery.  Pesch and Schroeder (1996) explore the 
extent to which variables including plant size and number of product lines determine the level of 
factory focus.  Similarly, MacDuffie, Sethuraman and Fisher (1996) study productivity in auto-
motive manufacturing and find that focus on the number of models does not negatively impact 
productivity, but focus on the number of parts does.  Brush and Karnani (1996) also study the 
effect of focus on manufacturing productivity.  Following an empirical examination of US manu-
facturing firms from 1972 to 1984, they find limited support for the argument that plant focus 
increases productivity. Suarez et al (1996) show the benefits associated with focus in the printed 
circuit board industry.  Lapré and Scudder (2004) find that airlines that cherry pick routes and 
less congested airports tend to have fast turnaround times for their planes.  Tsikriktsis (2007) also 
looks at the strategic effects of focus in the US Airline industry and finds that focused airlines 
significantly outperform their competitors.  Collectively, these papers argue that the benefits of 
focus more than offset any gains achieved from an increase in product variety.  
 Organizational learning is one of the mechanisms through which focused operations can 
generate process improvements.  For example, Lapré et al (2003) find that the development and 
dissemination of knowledge is an important driver of quality improvements.  However, an in-
crease in process complexity can impede learning and hinder process improvements. Tucker et al 
(2007) argue that in healthcare delivery, where medical knowledge is constantly changing, 
knowledge transfer is especially important.  Using data from several Intensive Care Units, they 
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demonstrate that learning activities have an appreciable impact on the quality of care.  Similarly, 
Lapré and Tsikriktsis (2006) explore the effects of organizational learning on focus.  They look 
at the strategic effects of focus on reducing customer dissatisfaction in the US Airline industry 
and find that although the average focused airline did
 
not learn faster than the average full-
service airline, the best focused airline did.  Although our paper does not specifically focus on 
learning, we point out organizational learning as a potential source of gains at focused factories. 
Huckman and Zinner (2008) study the benefits of focus in the management of clinical tri-
al sites. They distinguish the effects of focus at the firm level from the effects of focus at the di-
visional level. They explain how by using Skinner’s concept of a “plant within a plant” some of 
the sites in their sample appear to be unfocused if looked at from an aggregate perspective (these 
sites are involved in clinical trials and they provide traditional patient care), yet focus at the op-
erational (divisional) level by maintaining separate and dedicated divisions (branches in the lan-
guage of the authors) for the associated patients. We follow Huckman and Zinner (2008) and 
separately measure focus at the firm (hospital) levels as well as within the operating unit (cardi-
ology department). 
Generations of MBA students have been exposed to the idea of focused operations based 
on the Shouldice Hospital case (Heskett 1983). The case highlights several process-specific and 
patient-specific factors that improve patient care.   For example, in order to reduce post surgery 
recovery time, local anesthesia is used as a cheaper and safer alternative to general anesthesia.   
Similarly, following surgery, patients are encouraged to engage in moderate physical activity in 
order to help reduce recovery time and overall hospital stay.  On the other hand, Shouldice Hos-
pital is also known to enforce a stringent patient selection process.  Prospective patients are re-
quired to fill out a lengthy questionnaire prior to admission, and are screened for eligibility.  For 
example, applicants who are overweight must lose weight before they can be admitted.   Lee et al 
(2009) explore the impact of individual patient characteristics on the performance of healthcare 
delivery, and find that patient heterogeneity can significantly impact both patient admissions and 
service rates amongst individual service providers.  Broadly speaking, the development of a fo-
cused strategy is a complex decision that requires identifying target market segments and firm-
level operational competence. 
There has been recent interest in the medical community on specialty hospitals, which 
have been compared to focused factories (see Casalino et al 2003 and Shactman 2005).  Estimat-
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ing the productivity and quality of these hospitals, however is confounded by several factors.  As 
Iglehart (2005) notes, superior physician productivity and quality may result from repeatedly 
performing a narrow set of procedures.  On the other hand, selective admission of patients can 
also be a driver of superior outcomes.  Disentangling these two effects to estimate the process-
specific gains at focused hospitals is not trivial.   Cram et al (2005) compare the outcomes of 
cardiac surgery patients at specialty hospitals by accounting for a number of observable controls.  
They find that specialty hospitals often choose low-risk patients.  Greenwald et al (2006) conduct 
a series of hospital-level observations and reach similar conclusions, i.e. patient selectivity is 
shown to exist at specialty hospitals.  Similarly, Barro et al (2006) consider the market-wide ef-
fects of a specialty hospital.  By comparing population level outcomes amongst hospital markets 
that differ in whether they experienced a focused entry or not, they find support for market-wide 
efficiency gains resulting from a specialty hospital’s entry.  However, these papers do not sepa-
rately identify the effect of operational gains due to focus and the effect of patient selectivity 
(“cherry picking”).  Furthermore, the literature on specialty hospitals has not considered the im-
pact of multiple levels of organizational focus on outcomes.  We find that the levels of organiza-
tional focus, as well as patient selectivity can affect outcomes. 
3. Medical Context: Cardiac Care 
Our choice of cardiac care delivery as the empirical setting of our research is motivated by three 
reasons. First, any direct and objective comparison of operational performance requires choosing 
a specific industry context. It is simply difficult to compare absolute levels of quality of a hotel, 
an airline, and an automotive plant. Cardiac care delivery is particularly well suited for inter-firm 
comparisons of operational data because of quantifiable and objective performance metrics.  Our 
analysis examines the effects of focus on a hospital’s service quality as measured by its patient 
mortality and on its service time as measured by the patient’s length of stay. Both of these me-
trics are measured in all hospitals and have extensively been used in prior studies in Operations 
Management (e.g. Pisano et al 2001, and Kc and Terwiesch 2009) and Healthcare (e.g. IHI 
2008).  In addition, from a research design perspective, there exists a large body of medical lite-
rature on risk adjustment of cardiac patients, which allow for a reliable patient level risk adjust-
ment of outcomes.  Second, cardiac care is a high volume and high revenue service sector that 
accounts for a third of the entire patient volume in the US and over a third of all Medicare spend-
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ing (American Heart Association 2010).  This sheer economic importance and its impact on pub-
lic health alone make this a setting worthy of extensive research. Third, recent developments 
within the health care industry have re-ignited an interest in the service focused factory (e.g. 
Herzlinger 1997).  Specialty hospitals, which are focused hospitals that specialize in a limited 
number of types of treatments, have generated significant attention from both policy makers and 
care providers.  A recent study conducted by the US Government Accountability Office (GAO 
2003) reported a three-fold increase in the number of specialty hospitals between 1990 and 2003.   
This rapid proliferation of specialty hospitals underscores the need to better understand the effect 
of focus in healthcare delivery, and to examine the impact of a focused firm on the competitive 
landscape.     
To examine the effect of focus on hospital performance, we collected patient level dis-
charge data from California hospitals from 2007.  The hospitals in our data set vary greatly in 
their degree of focus.  Similarly, patients vary in their risk factors, including age, gender, diagno-
sis, payer, and travel distances to hospitals.  Our objective is to estimate whether the degree of 
focus determines our patient level outcomes of interest, including mortality rate and length of 
stay.  
As a preliminary analysis, consider the data shown in Table 1. The table compares the aver-
age LOS, the standard deviation of LOS, mortality, and the average Charlson index (a broad 
based measure of patient risk) across patients in focused and non-focused hospitals. For the pur-
pose of Table 1, we classified a hospital as focused (unfocused) if it had a larger (lower) than 
median percentage of its patients admitted for cardiac problems. 
Observe that cardiac-focused hospitals have patients with a lower average value of the Charl-
son index, indicating lower risk. Note further their lower average standard deviation in the length 
of stay, 0.12 for the cardiac-focused and 0.32 for the non-focused hospital. In line with Skinner’s 
argument, Table 1 also shows that patients at focused hospitals generally exhibit lower average 
lengths of stay and lower mortality rates than do patients at non-focused hospitals. Based on the 
superior operational outcomes of cardiac-focused hospitals as revealed by our preliminary analy-
sis in Table 1, it is not clear whether some or all of the gains are due to operational efficiencies 
versus patient selection.  Similar reports (Greenwald 2006, Leapfrog 2002) suggest both sources 
as possible drivers of outcome improvements. As we argue in the following section, one needs to 
be careful in interpreting the data in Table 1. 
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4. Theory and Model Development 
We now develop a set of concise hypotheses with respect to the effect of focus on performance 
as measured by patient outcomes. Let  be the outcome measure of patient i’s treatment at hos-
pital h.  In the following discussion, we will focus on this general outcome measure, while in the 
subsequent estimation of our model, we will use the lengths of stay (LOSi) and incidence of mor-
tality (MORTi) as specific measurements of . 
Assuming a linear, additive model of operational performance, we can write: 
Yih = δ + Piβ + Hhγ + φFocusi + uih   (1) 
where Pi is a vector of patient-specific covariates including gender, age, diagnosis, type of pro-
cedure and type of payer.  Hh is a vector of the hospital level observables such as size, location 
and patient volume.  The variable Focusi is a measure of the degree of focus associated with the 
care for patient i was treated and uih captures the effect of all other variables which are unobserv-
able to the researcher.  The model specified by (1) allows us to examine the effect of a conti-
nuous measure of focus and also adjusts the outcomes for various patient specific (Pi) and hos-
pital specific (Hh) variables that are unrelated to focus. This ensures that we are truly measuring 
the effect of focus instead of confounding it with effects such as the patient risk or the size of the 
hospital.   
In our discussion of focus, we will follow the argument of Huckman and Zinner (2008) 
and define focus at multiple levels of analysis. Specifically, we examine the effects of focus at 
three distinct levels of the organization, and compute Focusi at the firm level, the operating unit 
level, and at the process flow level. 
We begin our analysis by also examining the effect of focus on outcomes at the firm (or 
hospital) level.  Consider our research setting of cardiac care. Prior research investigating the 
benefits of focus in this setting has measured focus as “the percentage of patients in a particular 
hospital in a particular year whose primary diagnosis […] falls in the area of cardiovascular dis-
ease (GAO 2003)”.  In other words, a hospital is focused on cardiovascular services if a large 
fraction of its patients will be treated in the cardiology department, relative to the other depart-
ments within the hospital.  Previous research on the benefits of focus in hospital operations (e.g., 
Clark and Huckman 2010, Greenwald 2006) has examined focus at this level of the organization.   
Like other researchers before in healthcare operations (Clark and Huckman 2010, Greenwald 
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2006), we define firm level focus to be the proportion of cardiac patients in the entire hospital 
(cardiac patients / total patients) and hypothesize that: 
H1: Firm level focus is associated with better patient and hospital adjusted operational 
outcomes (φ<0), including shorter lengths of stay and lower likelihood of mortality. 
A hospital whose cardiovascular patients comprise a large fraction of the total hospital-
wide admissions volume however might still have a cardiology department that is not focused. 
Cardiac patients require treatment for an array of cardiac ailments, including arrhythmia (irregu-
lar heart beat), tachycardia (excessively rapid heartbeat), coronary artery disease, or pericardial 
effusion (fluid around the heart). While all these conditions fall under the broad classification of 
cardiovascular diseases, they require very different resources and medical interventions. A pa-
tient with arrhythmia might be treated by implanting a pace maker, a patient with coronary artery 
disease might be treated with a cardiac bypass surgery, and a patient with pericardial effusion 
might be treated with anti-inflammatory drugs or steroids.  Thus, at the firm level, a hospital 
might have a focus on cardiology patients. But it might have a rather diverse set of cardiac treat-
ment protocols that reduce focus at the level of its cardiology department (or operating unit). 
To measure the operating unit, or the focus within the cardiology department we define 
the department’s focus on revascularization procedures as the percentage of all cardiac patients 
that receive a coronary revascularization procedure.  That is, operating unit focus = revasculari-
zation patients / cardiac patients. A coronary revascularization is a surgical procedure that in-
volves bypassing blockages or obstructions in the coronary arteries in order to restore blood flow 
to the heart muscle. Patients requiring such a procedure all have one or more clogged arteries. 
Moreover, this group of patients is relatively homogenous in their level of risk (e.g. McClellan et 
al., 1994). From an operating unit perspective, revascularization patients experience a common 
care path starting with pre-operative planning, hospital admission, surgery, ICU recovery, dis-
charge to an observation unit, and ultimately a discharge from the hospital. For these reason, one 
can think of the operations for the “product line” of revascularization patients in line with Skin-
ner’s concept of a plant-within-a-plant.  We postulate that the benefits of focus increase as the 
unit of analysis becomes more granular, i.e. as we move from studying firm (hospital) level focus 
to operating unit (or cardiac department) level focus. 
H2: The benefits of focus are higher at the operating unit level (focus on the set of revas-
cularization patients within cardiology) than at the firm level (focus on cardiac care). 
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In addition to a cardiology department’s focus on revascularization, we develop an even 
more granular measure of focus.  While homogenous in their need for some surgical intervention, 
revascularization patients differ in terms of which exact intervention they require. The two most 
common surgical interventions for revascularization patients are a coronary artery bypass graft 
(CABG) procedure and a percutaneous coronary intervention (PCI) procedure, commonly known 
as a coronary angioplasty.  A CABG procedure is an open-heart surgery, which requires making 
an incision on the sternum to access the heart, and subsequently restoring blood flow to the heart 
muscle by by-passing the clogged artery with a donor vessel.  On the other hand, a PCI is a rela-
tively minimally invasive procedure; this procedure involves inserting a catheter and mechani-
cally widening the narrowed or obstructed blood vessel, and obviates the need to open up the pa-
tient’s chest.  Medical research (e.g. McClellan et al., 1994) has compared the pre-operative risk 
amongst revascularization patients who undergo CABG versus PCI, and find that the two groups 
of patients are similar in terms of pre-operative risk levels.  
Although both groups of revascularization patients follow the same care path described 
previously, they differ as far as two operational aspects are concerned. First, they use different 
resources, in particular different doctors performing the surgical intervention. A CABG surgery 
is performed by a cardiothoracic surgeon while a PCI is performed by an interventional cardiolo-
gist. Second, given the minimally invasive nature of PCI, the two groups differ with respect to 
their activity times along the care path.  
Mixing CABG and PCI patients thus creates variability across patients in activity times, 
in particular with respect to the time patients spend in the ICU and in post-ICU recovery.  Such 
variability, in turn, is associated with significant losses in throughput and longer flow times (see, 
e.g., Cachon and Terwiesch 2008 or any other introductory Operations Management book for 
discussions on how variability in activity times reduces process throughput and increases wait 
times).  By focusing on CABG procedures, a cardiac unit may thus be able to reduce such varia-
tion in activity times, and ultimately improve patient length of stay.  As the unit of analysis be-
comes more refined, we not only increase the degree of specialization of the care resources, but 
also reduce the flow variability in the care process. This should improve the patient flow and 
hence improve the length of stay and outcomes.   
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In our analysis, we choose to focus on CABG procedures, which are surgically more in-
vasive, more complex, and generally more time consuming than PCI. Thus, to examine the effect 
of process-level focus on outcome, we analyze revascularization patients who have a CABG.  To 
examine this focus on a particular patient profile, we define a cardiology department’s focus on 
CABG patients as the percentage of revascularization patients that undergo a CABG procedure.   
In short, process focus = CABG patients / revascularization patients. 
H3: The benefits of focus are higher at the process level (focus on a specific cardiac pro-
cedure) than at the operating unit level (focus on revascularization patients) 
Next, we argue that the benefits from focus are cumulative; focus at each of the three or-
ganizational levels (viz. firm, operating unit, and process) will independently drive improved 
outcomes for a given patient.  Said differently, CABG patients who are admitted to a hospital 
with process flow level of focus will derive additional operational benefits if the operating unit 
and firm are also focused.  We argue that this is due to the fact that some of the drivers of firm, 
operating unit, and process focus are independent.  For example, firm level focus may result 
from a better managed cardiac ICU, which is used to treat all cardiac patients; operating unit fo-
cus may result from better peri-operative diagnosis capability for treating revascularization pa-
tients; process level focus could be due to having a skilled CABG surgeon and better post-
operative care in preventing sternum wound infections.  That is: 
H4: The benefits of organizational focus are cumulative. 
As a result of a selective admission policy in focused hospitals, the coefficient estimate of 
φ captures the aggregate gains achieved from focus, but it does not distinguish between the gains 
due to better service delivery from the gains due to targeting a specific patient profile. According 
to the SSV framework proposed by Heskett (1986), targeting a customer market and service de-
livery excellence are two separate organizational capabilities of service firms.  Firms can excel in 
one or both of these areas.  That is, some firms are good at picking the right customers, and some 
are good at service delivery.  Distinguishing between these two capabilities is important. For ex-
ample, a policy maker or a hospital manager engaged in benchmarking hospitals needs to under-
stand how much of the performance advantage from focused hospitals is due to superior opera-
tions and how much reflects a selective admission policy. In other words, they need to control 
for the effect that focused hospitals seek to treat an easier patient mix. 
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Some of the differences in patient characteristics are observable to us as researchers. For 
example, our patient level data includes information about the age of the patients and the most 
important co-morbidities. These variables are part of the previously introduced vector, Pi, in our 
regression model (1). In particular, we use patient level medical information, including age, 
gender, the Charlson index (a commonly used measure of risk, see Charlson et al 1987 for de-
tails), and various diagnoses in order to produce a pre-admission level of mortality. Thus, unlike 
the analysis underlying Table 1, the regression model (1) appropriately controls for differences in 
Pi across patients. To test for a cherry picking behavior of focused hospitals, we simply need to 
compare the patient characteristics across focused and un-focused hospitals. We thus hypothes-
ize:  
H5: Patients treated in focused hospitals have, on average, a lower pre-operative risk of 
mortality compared to patients treated in a non-focused hospital.  
While the variables in Pi can control for heterogeneity in patient characteristics across 
hospitals, they are not sufficient to control for all differences in admission policies. Other va-
riables, such as prior relationships between hospital and patient, data revealed in lab reports, or 
details only visible on imaging studies, might also influence in which hospital a particular patient 
i is likely to be treated. This is problematic from an econometric perspective. An essential as-
sumption underlying an estimation based on (1) is that the error term uih is not correlated with 
any of the explanatory variables, including Focusi.  In other words, the model implicitly assumes 
that patients are assigned randomly to hospitals and not based on some unobservable patient cha-
racteristics included in uih. Thus, in addition to controlling for the observable variables in Pi, we 
also need to account for unobservable differences in patient admission. We do this by using an 
instrumental variable (IV) estimation technique based on the levels of focus in the set of hospit-
als in proximity to the patient’s home. This approach provides a quasi natural experiment and 
thereby mimics a random patient-to-hospital assignment. 
With this IV estimation strategy, we can determine if and to what extent focus leads to 
superior operations. Beyond the benefit of selective patient admission, focused hospital might 
simply benefit from specialization and the associated learning and thereby obtain a higher level 
of operational performance. Thus in keeping with this line of reasoning and the argument made 
by Heskett (1986), we thus hypothesize that the benefits of focus can exist even after accounting 
for the benefits of selective patient admissions: 
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H6: A focused hospital is associated with better patient and hospital adjusted operational 
outcomes (φ<0), including shorter lengths of stay and lower odds of mortality, even after con-
trolling for its selective admissions policy 
5.  Data Collection and Variable Definition 
Our empirical analysis is primarily based on a data set published by the California Office of 
Statewide Health and Planning (OSHPD), which includes observations for every inpatient dis-
charge in the state of California from 2007.   In addition, we use the Dartmouth Atlas of Health-
care to obtain information with respect to hospital markets.  
In order to account for market specific effects, we follow the Dartmouth Atlas of Health-
care’s classification to designate hospital markets based on the health referral regions (HRR).  
Hospital referral regions (HRRs) represent regional health care markets for tertiary medical care.  
In the Dartmouth Atlas, each HRR has been defined to contain at least one hospital that per-
formed major cardiovascular procedures. Minor modifications were made to the HRR’s to 
achieve geographic contiguity.  
We use the OSHPD data set to account for our patient level variables. In addition to the 
outcome variables (length of stay and mortality), we control for patient demographic factors that 
could influence outcome, including patient age, gender and race.  We also control for medical 
measures that have been known to significantly affect outcome, such as the diagnosis, overall 
medical condition of the patient at admission, as well as a range of clinical conditions including, 
hypertension, chronic renal failure, diabetes, chronic obstructive pulmonary disease, cerebrovas-
cular disease, peripheral vascular disease, congestive heart failure, current myocardial infarction 
(heart attack), and any previous incidence of a myocardial infarction.  In addition, we control for 
patient insurance status.  Table 2a provides some patient-level summary statistics.  Patients with 
one or more cardiovascular diagnosis were classified as cardiac patients. We see that the average 
length of stay for cardiac patients in California is 4.31 days, and the average mortality rate is 
2.4%. 
Next, we sought to identify the various sources of heterogeneity at the hospital level.    
From the OSHPD data set, we computed the aggregate inpatient volume at each hospital as well 
as the volume of admissions that occurred primarily for cardiac related causes.  The number of 
cardiac admissions divided by total number of admissions (or the fraction of cardiac-related ad-
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missions) was used as our measure of hospital (or firm) level focus.  The mean hospital level fo-
cus was estimated to be 12.4%, and the standard deviation was 7.3%.  Similarly, we find that the 
mean level of cardiac department focus (number of revascularization patients / number of cardiac 
patients) is 13.7% and its standard deviation is 14.1%.  The mean of the process flow level of 
focus (number of CABG patients / number of revascularization patients) is 40.7% and its stan-
dard deviation is 29.8%.  Figures 1a through1c provide a distribution of the levels of hospital, 
cardiac department and process flow focus in our sample.   We find that although 391 hospitals 
treat cardiac patients, only 187 hospitals perform coronary revascularizations and only 157 per-
form CABG procedures (Table 2b).   We also observe that the three measures of organizational 
focus are not strongly positively correlated, eliminating concerns about collinearity (Table 2c).   
In order to determine the pre-operative risk levels, we use a logistic risk adjustment mod-
el (see Kc, Terwiesch and Horak 2010) based on observed cardiac risk factors including age, 
gender, hypertension, chronic renal failure, diabetes, chronic obstructive pulmonary disease, ce-
rebrovascular disease, peripheral vascular disease, congestive heart failure, and myocardial in-
farction.  
We also used the hospital ZIP codes to infer the geographic categorization of the hospital.  
Specifically, the ZIP code allows us to identify the HRR.  Including the HRR fixed effect in our 
empirical specifications allows us to account for market-specific effects, including rural/urban 
categorizations, as well as market-specific economic factors.   
6.  Aggregate Effects of Focus 
The results of our empirical analysis are reported in Tables 3a-4b. We estimate using heteroske-
dasticity consistent robust standard errors clustered at the hospital level, in order to allow for dif-
ferences in the variance/standard errors due to arbitrary intra-group correlation. Table 3a summa-
rizes the results of the OLS regression analysis with the length of stay as the dependent variable, 
a side-by-side comparison of the impact of each of the three levels of focus on the length of stay.  
Table 3b summarizes the effect of the probit regression on the post-operative mortality rate as 
the dependent variable.  These specifications include all the observed covariates including pa-
tient and hospital level observables.  To simplify the exposition of our results, we do not show 
these control variables in the results tables.  
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We note that the three specifications in Tables 3a and 3b are applicable to distinct patient 
populations, as indicated in our hypothesis development.  The relevant patient population in col-
umn (1), which examines the effect of firm (or hospital) level focus, is the set of all cardiac pa-
tients; the relevant patient population for examining the effect of operating unit (or cardiac de-
partment) is the set of all revascularization patients; the effect of process (or CABG procedure) is 
examined on all patients who undergo a CABG. 
First we consider the effect of firm (hospital) level focus.  The regression analysis of equ-
ation (1) estimates the coefficient for hospital level focus to be -0.388 (p < 0.01), implying that 
hospital stays for patients are 3.88 % shorter for a focus increase of 10%.  This supports Hypo-
theses 1.  As discussed previously, this estimate captures the aggregate effects of focus. The re-
gression shows that hospitals with hospital level focus have shorter lengths of stays, even after 
adjusting for a number of observable patient and hospital level variables.  We obtain similar qua-
litative results for the effect of focus on the likelihood of mortality.  We find that focus is asso-
ciated with a reduced likelihood of mortality (coefficient estimate -0.315, p = 0.1 see Table 3b), 
in support of Hypothesis 1.   
Consistent with the presence of economies of scale, we find that an increase in volume is 
associated with a reduction in both lengths of stay and odds of mortality. Economies of scale 
might reflect efficiency gains driven by volume-induced learning. Alternatively, they might re-
flect a better availability of various treatment and diagnostic services that can influence the 
length of stay (e.g. radiology, respiratory services, lab testing).  
Next, we compare the effects of focus at the two lower levels of the organization (col-
umns 2 and 3).  We find that operating unit (cardiac department) focus is associated with a re-
duction in the length of stay.   In particular, a 10% increase in cardiac department focus is asso-
ciated with a reduction in the length of stay by 4.92%. This is larger in magnitude (although not 
statistically different) compared to the 3.88% reduction in length of stay due to a similar increase 
in focus at the hospital level.  We find process level focus does not have a statistically significant 
impact on reducing the length of stay.    
The results in Table 3b show that focus at all three levels of the organization is associated 
with a reduction in the likelihood of mortality.  The coefficient estimates for firm, operating unit 
and process level focus are -0.315, -0.345, and -0.564 respectively.  These findings provide sup-
port for hypotheses 2 and 3 (i.e. process level focus has a greater impact than operating unit fo-
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cus, which has a greater impact than firm level focus).  The coefficient of -0.315 for the effect of 
hospital level focus corresponds to a reduction in the probability of mortality by 0.051% for the 
average cardiac patient with a predicted mortality rate of 2.43 % for a 0.l unit increase in focus; 
this corresponds to a percentage reduction in mortality by a factor of 2.1%.  Similarly the coeffi-
cient estimate of -0.345 for the effect of cardiac department focus implies that a 0.1 unit increase 
in cardiac department focus reduces the probability of mortality by 0.041% for the average re-
vascularization patient with a predicted mortality rate of 2.74%; this corresponds to a percentage 
reduction in mortality by a factor of 1.50%.   Finally the coefficient estimate of -0.564 for the 
effect of process level focus implies that a 0.1 unit increase in cardiac department focus reduces 
the probability of mortality by 0.165% for the average CABG patient with a predicted mortality 
rate of 2.93%; this corresponds to a percentage reduction in mortality by a factor of 5.6%.    
We also find that hospital volume is associated with a reduction in the mortality rate for 
cardiac patients.  This finding supports and extends the results from Peterson et al (2004), Halm 
et al. (2002), Luft et al. (1987) and Sollano et al. (1999) who have previously found that volume 
improves outcome.   In addition to the effect of hospital volume on the outcomes for all cardiac 
patients, we make two more findings for the effect of volume on outcome.  First, we look at the 
effect of volume on length of stay. Previous work has focused on primarily mortality and mor-
bidity outcome measures.  Second, we look at both hospital level volume and cardiac department 
volume on outcomes.   Prior work has not considered the effect of these two organizational le-
vels of volume.   We find that where statistically significant, both cardiac and hospital volume 
have the effect of reducing LOS and mortality rates. 
Finally, we examine the effect of the three levels of organizational focus on the smallest 
subset of patients to which all three measures of focus are applicable, viz. the set of CABG pa-
tients.   Tables 4a and 4b provide the results for the effects of firm focus (column 2), operating 
unit focus (column 3), and process focus (column 4) on this small subset of 18,797 patients.   
Column (5) provides the effect of all three measures of focus on the outcome for this patient 
population.   The results show that firm, operating unit, and process focus do not have a statisti-
cally significant effect on the LOS.  Although firm and operating unit focus have an effect on 
reducing the LOS for all cardiac patients and all revascularization patients respectively (as dis-
cussed previously), focus at these higher levels of the organization do not appear to impact the 
CABG patients.   However, we find that all three measures of organizational focus have an effect 
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of improving the mortality rates for the patients undergoing CABG.   In addition, we find that 
some of these benefits are cumulative.  Table 4b column 5 provides the effect of all three meas-
ures of focus on the mortality rate for CABG patients.  We see that operating unit focus and 
process focus have a significant effect on reducing the mortality rate.   While each measure is 
statistically significant in at least one regression, firm level focus is not statistically significant in 
the model that includes all three measures.  Although LOS is unaffected, mortality is reduced 
through focus.   
7. Effects of Selective Admissions 
The previous results simply show the aggregate benefits of focus. They do not disentangle the 
effects of patient selection and service delivery. To test whether or not focused hospitals admit 
easier to treat patients (Hypothesis 5) and to determine if and to what extent their operations are 
producing better patient outcomes even when we control for selective patient admissions (Hypo-
thesis 6), additional analysis is needed. In this section, we will first test Hypothesis 5 (7.1). We 
will then introduce our IV estimation strategy (7.2) and then report our IV estimation results, in-
cluding the test of Hypothesis 6 (7.3). 
7.1 Evidence for Selective Admissions  
Table 5 provides the average pre-operative risk adjusted mortality rate as a function of hospital 
level, cardiac department and process level focus.  Specifically, we examine whether hospital 
focus, cardiac department focus, and process focus are associated with lower pre-operative mor-
tality risks for all cardiac, all revascularization, and all CABG patients respectively.  For the 
former two measures of focus, we find a negative correlation between focus and the pre-
operative risk levels of patients.  The statistically significant and negative coefficients for hospit-
al level focus and cardiac department focus suggest that focused hospitals admit patients with 
lower pre-operative levels of risk.  This provides support for hypothesis 5 (cherry picking).   
However, at the process level, focus is not significant. In other words, hospitals that pri-
marily perform CABG procedures do not seem to cherry pick from the available pool of CABG 
patients. One potential explanation for this is that a hospital that wants to obtain a focus in 
CABG might need to admit a broader set of CABG patients in order to reach a minimum level of 
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scale.  Another possible explanation it is more difficult to further discriminate on risk amongst 
this group of patients that is already quite specialized.   In other words, at the hospital level, it is 
easy to distinguish between a low-risk routine patient who can be treated with medications and a 
high patient who needs a CABG.  However, at the process level, the group of CABG patients has 
similar kinds of risk and resource needs. 
7.2 Instrumental Variable Estimation Strategy 
The results from Table 5 suggest that focused hospitals admit lower risk patients.  This risk ad-
justment is based on observed measures of patient risk.  By including these sources of patient 
heterogeneity in (1), we are able to account for observed patient level risk factors that drive out-
comes.  However, many attributes that determine the patient risk and his admission to a focused 
hospital, are not directly observable to us as researchers.  Therefore, a simple ordinary least 
squares (OLS) regression estimate of (1) may yield a biased effect of focus on outcomes due to 
the confounding effects of patient selectivity.   
In order to circumvent this estimation challenge and still produce a consistent estimate 
for φ, we employ an instrumental variables technique. Our technique allows us to estimate the 
effect of hospital focus on outcomes, without the need for an explicit observation of the admis-
sion process and the various drivers of patient selection. To estimate this unbiased effect of fo-
cus, we need to look at the outcome of a patient who was admitted to a focused hospital, but for 
whom his medical characteristics (his suitability for a focused hospital) did not factor into the 
admission decision.  In other words, estimating φ is feasible if we could randomly assign patients 
to hospitals (independent of the medical drivers of patient selection), as in a controlled experi-
ment.  
Practically, such a large scale controlled study is not feasible.  However, the subsequently 
described instrumental variables estimation approach allows us to evaluate the outcomes of pa-
tients as if they were randomly assigned to focused hospitals. Basically, an instrumental variable 
allows us to exploit variation in the assignment of patients to hospitals that is unrelated to the 
unobserved confounding factors (unobserved medical characteristics) and then utilize this varia-
tion to extricate the effects of focus on outcome.   We refer the readers to Wooldridge (2002) for 
a comprehensive overview of instrumental variable estimation.   
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The instrumental variables that provide this exogenous variation are the levels of focus 
(Focusik) in the set of K hospitals that vary in their relative distance from patient i’s home (see 
McClellan, McNeil and Newhouse 1994 for use of the differential distance as an instrumental 
variable to evaluate the quality of competing treatment strategies for cardiac patients).  To see 
the validity of this set of instrumental variables, consider the factors unobserved by the research-
er, such as the presence of specific known co-morbidities, or the presence of a rare medical con-
dition. It is reasonable to assume that these unobserved variables that determine patient risk are 
identically distributed in the patient population. Consequently, the relative travel distance (the 
additional distance that the patient would have had to travel to get to a focused hospital) is un-
likely to be correlated with patient characteristics, captured by uih. In other words, a patient’s un-
observed medical characteristics should not be correlated with the relative travel distances to a 
given set of hospitals or their degrees of focus. Thus, conditioning on the observed variables, the 
levels of focus in the set of K nearby hospitals, Focusik (for k = 1…K), must be uncorrelated with 
the outcome variables. 
Although the relative travel distance should be uncorrelated with the patient severity lev-
el, it is likely to be correlated with the patient’s eventual choice of hospital.  The further a patient 
has to travel to get to a focused hospital, the lower the likelihood of the patient being admitted to 
one.  One reason for this is that hospitals in close proximity are more likely to already have a 
prior relationship with that patient.  In the event of an emergency, a patient is more likely to be 
admitted to a hospital that can be reached in a short period of time.  It is thus sensible to assume 
that ceteris paribus, a patient would be more likely to choose a focused hospital if they live in 
close proximity to one.   
Consider patient i, whose choice set consists of the hospitals in Hi.  Let p(i,k)  denote the 
probability that patient i visits hospital k, where k is the index for the hospitals in Hi. In particular 
k=1 denotes the closest hospital in the choice set, k=2 denotes the second closest hospital and so 
on.  For each patient i who visits a hospital, we can say 
 
Because greater travel distance is associated with a reduced likelihood of visit, we expect p(i,k) 
to be larger for smaller values of k.  That is, the likelihood of a patient’s visit is higher for the 
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hospitals in closer proximity to the patient. Based on the above formulation the expected level of 
focus for patient i is simply  
 
where Focusik is the degree of focus at the k
th
 closest hospital to patient i.  The expected 
level of focus for patient i is thus simply the weighted average of the levels of focus of the hos-
pitals in his choice set, weighted by the probability of visit.   The levels of focus in the patient’s 
choice set, and their relative distances are expected to be uncorrelated with his underlying levels 
of severity.  Yet, these factors influence the patient’s assignment to a focused hospital.  In other 
words, the relative travel distances provide an approximation for the relative probabilities of vis-
it.  For example, if the closest hospitals happen to be highly focused, there is a greater likelihood 
of the patient being treated at a hospital with a high level of focus.  
This insight allows us to use Focusik as instrumental variables in producing an unbiased 
estimate for the effects of focus on outcomes.  We first derive an estimator for φ using the two-
stage least squares (2SLS) method to estimate (1) when the outcome variable of interest (Y) is 
log(LOS).   
The following first stage equation is based on the effect of relative distance (in the sense 
of the extra distance the patient has to travel to reach a focused hospital) on the degree of focus 
for patient i.  
 
The coefficient ρk represents the amount by which an increase in focus at the k-th closest hospital 
leads to an increase in the expected level of focus for patient i.  We expect the coefficient ρk to 
decrease in value in a stochastic sense as k increases; this reflects the fact that closer hospitals 
have a greater influence on patient choice.   
In the second stage of our two-stage least squares estimation we have, 
 
where  is the fitted value of  based on the first stage equation. Since this 
second stage equation controls for patient and hospital level variables associated with patient i in 
the same way as the first stage equation, any residual variation in  is thus attributed to 
variation arising solely from the relative travel distances. Consequently, the instrumental variable 
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estimator φIV allows us to estimate the effect of the travel distance induced variation in  
on the length of stay.  
Next, we examine the effects of focus on the quality of care.  Although the actual quality 
of care for patient i in hospital h (say Yih) is a latent variable, we do observe the incidence of a 
mortality (MORTih), which is determined by the quality of care.  That is, MORTih = 1[Yih > 0].  
We use a probit transformation of the binary dependent variable (MORT).  Unfortunately, we 
cannot use the 2SLS method to estimate the effect of focus because 2SLS does not produce con-
sistent estimates when the second-stage regression is non-linear (see Amemiya 1990 for an ex-
planation).  Therefore we use the instrumental variable based probit MLE method outlined in 
Woolridge (2002), pp 472-478 to obtain consistent estimates for the effect of focus on the like-
lihood of mortality.  
Finally, we make two comments about our instrumental variables.  First, our instrumental 
variable estimation strategy is based on a ranked ordering of hospitals.  This approach allows us 
to use a continuous measure of focus as the dependent variable.  Secondly, our analysis is per-
formed at three organizational levels of focus.  For example, the nearest hospital for a given pa-
tient might be unfocused at the firm level, but highly focused at the operating unit and process 
levels.  Since our analyses involve three separate measures of focus, we produce three distinct 
sets of corresponding instrumental variables, one for each level of organizational focus.   
7.3 Instrumental Variable Results 
In order to obtain the set of K closest hospitals, we first obtained the ZIP codes of the patient res-
idence and that of the hospitals in their choice set.  The distances between patient homes and the 
set of focused hospitals in California were then estimated by calculating the “crow’s flight” dis-
tances between the centroids of each patient’s residential ZIP code and the ZIP codes of the hos-
pitals. For each patient in our sample, we then sorted this corresponding set of hospitals by their 
relative travel distance, and obtained the set of K closest hospitals.  Finally, we computed the 
three levels of focus for each of these hospitals.    
The results of our IV estimations discussed above are displayed in Table 6a.  After con-
trolling for the selective admission effect, the previously reported benefits of hospital level focus 
vanish. Specifically, hospital level focus is no longer statistically significant in explaining varia-
tion in length of stay. Focused hospitals apparently obtain no length-of-stay reduction with re-
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spect to a patient chosen randomly from the overall patient populations. All acceleration benefits 
therefore seem to result from the admissions decision.   The Hausman specification test shows 
that that the estimator for firm (hospital) focus is endogenous (p = 0.0087), confirming the pres-
ence of selection bias. 
However, we find that the effects of operating unit (cardiac department) level focus con-
tinue to hold even for the patient that is quasi randomly assigned (-0.433). In fact, the corres-
ponding IV estimates are not statistically different from the previously reported OLS estimates.  
This finding suggests that selection effects are less important at lower levels of focus. At this 
level of the organization, the benefits of focus are thus real operational benefit.  The Hausman 
specification test does not reject the exogeneity of operating unit (cardiac department) focus (p = 
0.44) and process focus (p = 0.80).  This confirms that patient selectivity based on unobserved 
factors is not significant in biasing our estimates for the effects of operating unit level focus and 
process level focus.   
As shown in Table 6b, we find that the effects of focus on reducing the likelihood of mor-
tality for the randomly assigned patient disappear with our IV estimators. The coefficient esti-
mate for the IV estimator for hospital level focus, cardiac department level focus and process 
flow focus are statistically insignificant. We find that the Wald test rejects exogeneity at 0.108, 
0.133, and 0.975 levels for the hospital level, operating unit level, and process levels respective-
ly.   Thus, although we may not convincingly reject firm level endogeneity, we can reject endo-
geneity for the estimate of process and operating unit level focus; the probit results (Table 3b 
column 3) thus provide an unbiased estimate for the effects of process focus.   In other words, 
process focus has the effect of reducing mortality.  Similarly, the effects of operating unit (car-
diac department) focus are also unbiased (at the 0.1 level).   When we perform the Wald test for 
firm, operating unit, and process level focus for CABG patients (Table 4b), we also fail to reject 
exogeneity at 0.749, 0.423, and 0.975 levels respectively.   Therefore, Table 4b provides un-
biased estimates for the effect of three levels of focus on outcomes for CABG patients.  
In summary, our analysis shows that all levels of focus are associated with shorter lengths 
of stay and reduced likelihoods of mortality as compared to non-focused hospitals.  However, 
when we separate the operational benefits from the selection benefits by effectively randomizing 
the assignment of patients to hospitals, we find that the benefits of focus to a randomly assigned 
patient depend strongly on the kind of organizational focus.  In particular, focus at the level of 
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the cardiac department continues to improve length of stay.  However, the benefits from hospital 
level focus disappear. 
8.  Conclusions 
Our econometric analysis of the effects of focus in the cardiac care delivery market in California 
establishes the following four results.   First, we show that focused hospitals demonstrate im-
proved outcomes in the delivery of cardiac care.  Specifically, we show that focused hospitals 
have shorter lengths of stay and lower odds of mortality compared to non-focused hospitals. 
 Second, we estimate the effects of focus at three different levels of the organization.  This 
is particularly important because much of existing literature on focused hospitals has examined 
focus at the level of the firm. We find that all three levels of focus are associated with improved 
outcomes.   However the more granular levels of organization focus have a greater impact on 
reducing length of stay and mortality rates than hospital level focus.    
Third, we separate the operational gains of focus from the admissions (patient selection) 
related gains. We show that focused hospitals admit lower risk patients. Fourth, we show that at 
the hospital level controlling for selective admissions, the operational benefits of focus are lower 
than what we had seen. At the hospital level, focus does not improve length of stay or mortality.  
Beyond its contribution to our understanding of focus, our results have practical implica-
tions for healthcare policy. Consider the question of how care should be provided by a set of 
hospitals in a region. From the perspective of policy maker tasked with providing care to all pa-
tients in need, our study finds both focused and general hospitals in a positive light.  General 
hospitals may be better equipped for treating the “harder-to-treat” patients whereas focused hos-
pitals are more effective with easy-to-treat patients.  This suggests a division of labor in which 
large teaching hospitals offer a broad array of services and deal with the severely ill patients.   
Focused hospitals do what they are best at – dealing with the easy to treat patients. Such a divi-
sion of labor would be fair, assuming one could create an effective and equitable payment plans 
that acknowledges the cherry-picking behavior of the focused hospitals.  If the large teaching 
hospitals are expected to handle those patients that no focused hospital wants to care for, they 
will end up treating more severely ill patients. This suggests that their payments should be ad-
justed for taking on higher risk and greater costs.  Exploring the effect of incentive schemes and 
reimbursement procedures on overall welfare is thus an important area of future research.  
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One potential limitation of our study is that only one hospital had cardiac percentages ex-
ceeding 60%.  According to the GAO’s definition (GAO 2003), a hospital is a specialty hospital 
if two-thirds or more of the patient population within fall under a major diagnostic category.  
Thus, the majority of hospitals that we studied are not considered specialty hospitals based on the 
GAO definition. It is thus plausible that the effects of focus may vary at higher degrees of focus. 
Examining the effects of focus at specialty hospitals is another area of future research. 
Future research also needs to further explore the effects of other variables that drive pa-
tient selectivity. In particular, observations on physician referral patterns can shed more light on 
the extent to which selective admissions contribute to operational performance.  Physician treat-
ment patterns may also significantly drive outcomes (e.g. see McGlynn et al 2003).  It would 
therefore be useful to understand the micro-level decision making by individuals and physicians.  
A comprehensive data collection effort and research into the choices made by the key stakehold-
ers would greatly further our understanding of the drivers of healthcare outcomes. 
From hotels to hospitals and from financial services to airlines – operational focus has of-
ten been a source of competitive advantage. Future research needs to replicate our theoretical 
framework with its distinction between operational gains from focus and the selection gains as-
sociated with “cherry picking”.  Furthermore, as we have found, the operational gains from focus 
also depend significantly on the level of the organization at which focus is evaluated.  While the 
relative magnitude of these effects will differ across industries, we believe that the theory and 
methods presented in the present study provide an important step towards deepening our under-
standing of focus. 
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Tables and Figures 
Table 1: Comparisons of Cardiac-Focused and Non-Focused Hospitals  
 
Characteristic Focused Hospital 
 
Non-Focused Hospital 
Mean Charlson Score 1.208 1.221 
Average Length of Stay (days) 3.96 5.47 
Standard Deviation of LOS (days) 0.12 0.32 
Mortality Rate  2.47% 2.65% 
N (hospitals) 195 193 
Focused hospital and non-focused hospitals are categorized with Hospital Level Focus values above and below the median re-
spectively. 
 
 
Table 2a:  Patient Summary Statistics  
 
Characteristic Mean Standard Deviation Median 
Length of Stay (Days) 4.311967 13.27444 3 
Mortality Rate .0241309 .1534557 0 
Age Unknown .059486 .2365323 0 
Under 1 year .0047818 .0689852 0 
1–17 years .0073316 .0853103 0 
18–34 years .0197667 .1391978 0 
35–64 years .3636921 .481062 0 
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65 years or greater .5449417 .4979766 1 
Gender unknown .1816952 .3855935 0 
Female .4247148 .4943001 0 
Male .39359 .4885462 0 
Income ($) 54,208.21 21,196.18 50,092 
Unscheduled at least 24 hours 
prior to admission 
.8431811 .3636303 1 
Travel Distance (miles) 15.25758 112.2278 5.003141 
Charlson Index 1.239023 1.395788 1 
Myocardial Infarction for 
Current Admission 
.1308896 .3372799 0 
Prior Myocardial Infarction .1147557 .3187272 0 
Congestive Heart Failure .3264827 .4689266 0 
Peripheral Vascular Disease .0717373 .2580527 0 
Cerebrovascular Disease .028659 .1668463 0 
Chronic Obstructive Pulmo-
nary Disease 
.199072 .3993027 0 
Diabetes .2701279 .444 0 
Chronic Renal Falure .1989361 .3992003 0 
Hypertension .6913178 .4619501 1 
n = 500437 patients.  
 
Table 2b: Hospital Summary Statistics 
 
Characteristic Mean 
 
Standard Deviation Median 
Volume 10012 8784 7332 
Firm (Hospital) Focus 0.124 0.073 0.116 
Operating Unit (Cardiac De-
partment) Focus
 
0.137 0.141 0.122 
Process Flow (Procedural) 
Focus
 
0.407 0.298 0.284 
n = 391 Hospitals 
 
Figure 1a: Distribution of Hospital Level Focus 
 
 
Figure 1b: Distribution of Cardiac Department Focus 
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Figure 1c: Distribution of Process Flow Focus 
 
 
Table 2c: Correlation between Levels of Focus 
 
Coefficient Hospital Focus Cardiac Department 
Focus 
Process Focus 
Hospital Focus 1.00   
Cardiac Department Focus 0.399 1.00  
Process Focus -0.138 -0.572 1.00 
 
 
Table 3a: Effect of Level of Focus on Log (Risk Adjusted Length of Stay)  
 
Coefficient (1) (2) (3) 
Intercept  0.656 *** 
(0.056) 
0.311  
(0.24) 
1.66 *** 
(0.45) 
Hospital Focus -0.388 *** 
(0.151) 
- - 
Cardiac Department Focus - -0.492 *** 
(0.104) 
- 
Process Focus - - -0.023  
(0.138) 
Log Hospital Volume -0.0387 ** (0.0178) 0.0499 (0.31) 0.033 (0.041) 
Log Cardiac Volume  -0.0144 (0.038) 0.026 (0.037) 
R-Square 0.379 0.688 0.387 
N 479412 67480 18797 
Clusters 391 187 157 
 30 
Asymptotic Standard Errors in Parentheses * 10 % Statistical Significance, ** 5% Statistical Significance, *** 1 % 
Statistical Significance. Standard Errors are clustered at the hospital level.   Patient level controls included age, 
gender, ZIP code household income, type of admission, DRG categorical variable, incidence of Myocardial Infarc-
tion, Congestive Heart Failure, Vascular Disease, COPD, Diabetes, Chronic Renal Failure, Hypertension, and the 
Charlson Index.  
 
Table 3b: Effect of Level of Focus on Risk Adjusted Mortality Rate  
 
Coefficient (1) (2) (3) 
Intercept  -2.01 *** 
(0.279) 
-2.17*** 
(0.519) 
-1.524 * 
(0.81) 
Hospital Focus -0.315 * 
(0.19) 
- - 
Cardiac Department Focus  -0.345 *** 
(0.137) 
- 
Process Focus - - -0.564 *** 
(0.185) 
Log Hospital Volume -0.074 *** 
(0.021) 
0.045  
(0.047) 
0.085  
(0.069) 
Log Cardiac Volume  -0.082 (0.052) -0.151 ** 
(0.069) 
Likelihood Ratio  
(Pr > Chi-Square) 
< 0.001 < 0.001 < 0.001 
N 467313 67307 18630 
Clusters 391 187 157 
Asymptotic Standard Errors in Parentheses * 10 % Statistical Significance, ** 5% Statistical Significance, *** 1 % 
Statistical Significance. Standard Errors are clustered at the hospital level. Patient level controls included age, 
gender, ZIP code household income, type of admission, DRG categorical variable, incidence of Myocardial Infarc-
tion, Congestive Heart Failure, Vascular Disease, COPD, Diabetes, Chronic Renal Failure, Hypertension, and the 
Charlson Index. A subset of DRGS’s predict failure perfectly for 12099, 173 and 167 cardiac, revascularization, 
and easy revascularization patients respectively, and were not used in the probit regression.  
 
Table 4a: Effect of Level of Focus on Log (Risk Adjusted Length of Stay) for CABG Patients Only 
 
Coefficient Controls 
(1)  
Firm Focus 
(2) 
Operating Unit Fo-
cus  
(3) 
Process Focus 
(4) 
All Focus (5) 
Intercept  1.70 *** 
(0.41) 
1.74 *** 
(0.43) 
1.66 ***  
(0.41) 
1.67 ***  
(0.45) 
1.739 *** 
(0.456) 
Hospital Focus - -0.0168  
(0.21) 
- - -0.157  
(0.23) 
Cardiac Department 
Focus 
- - 0.169  
(0.41)  
- 0.23 
(0.13)  
Process Focus - - - 0.0230  
(0.138) 
0.055  
(0.13) 
R-Square 0.3869 0.3898 0.3877 0.3870 0.3882 
N 18797 18797 18797 18797 18797 
Clusters 157 157 157 157 157 
Asymptotic Standard Errors in Parentheses * 10 % Statistical Significance, ** 5% Statistical Significance, *** 1 % 
Statistical Significance. Standard Errors are clustered at the hospital level.   Hospital volume is included in all of 
the specifications.  Cardiac department volume is included in all of the specifications except (2) and (5) because of 
collinearity with the construct for department focus as department focus is explained by cardiac volume and total 
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hospital volume. Patient level controls included age, gender, ZIP code household income, type of admission, DRG 
categorical variable, incidence of Myocardial Infarction, Congestive Heart Failure, Vascular Disease, COPD, Di-
abetes, Chronic Renal Failure, Hypertension, and the Charlson Index. Estimates available from authors.  
 
Table 4b: Effect of Level of Focus on Risk Adjusted Mortality Rate for CABG Patients Only 
 
Coefficient Controls 
(1)  
Firm Focus 
(2) 
Operating Unit Fo-
cus  
(3) 
Process Focus 
(4) 
All Focus (5) 
Intercept  -1.788 *** 
(0.81) 
-1.34 *  
(0.85) 
-1.69 **  
(0.81) 
-1.79 **  
(0.81) 
-1.067  
(0.855) 
Hospital Focus - -0.72 **  
(0.33) 
- - -0.442  
(0.335) 
Cardiac Department 
Focus 
- - -0.260  
(0.22)  
- - 0.384 ** 
(0.192)  
Process Focus - - - -0.564 ***  
(0.185) 
-0.622 ***  
(0.181) 
Likelihood Ratio  
(Pr > Chi-Square) 
< 0.001 < 0.001 < 0.001 < 0.001 < 0.001 
N 18630 18630 18630 18630 18630 
Clusters 157 157 157 157 157 
Asymptotic Standard Errors in Parentheses * 10 % Statistical Significance, ** 5% Statistical Significance, *** 1 % 
Statistical Significance. Standard Errors are clustered at the hospital level.   Hospital volume is included in all of 
the specifications.  Cardiac department volume is included in all of the specifications except (2) and (5) because of 
collinearity with the construct for department focus as department focus is explained by cardiac volume and total 
hospital volume. Patient level controls included age, gender, ZIP code household income, type of admission, DRG 
categorical variable, incidence of Myocardial Infarction, Congestive Heart Failure, Vascular Disease, COPD, Di-
abetes, Chronic Renal Failure, Hypertension, and the Charlson Index. Estimates available from authors.  
 
Table 5: Relationship between Levels of Focus and Pre-Operative Risk Levels 
 
Coefficient (1) (2) (3) 
Intercept  -4.086 *** 
(0.025)  
-3.939 *** 
(0.0497)  
-4.115 *** 
(0.062) 
Hospital Focus -0.452 *** 
(0.173)  
 - - 
Cardiac Department Focus - -0.902 *** 
(0.272)   
- 
Process Focus - - - 0.0772 
(0.123) 
R-Square 0.0172 0.0563 0.0025
 
Number of Patients 479412 67480 18797 
Number of Hospitals 391 187 157 
Asymptotic Standard Errors in Parentheses * 10 % Statistical Significance, ** 5% Statistical Significance, *** 1 % 
Statistical Significance. The pre-operative predicted mortality rate is logged to reduce the skewness in the distribu-
tion. 
 
Table 6a: Effect of Level of Focus on Log (Risk Adjusted Length of Stay) with Instrumental Va-
riables 
 
Coefficient (1) (2) (3) 
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Intercept  0.665 *** 
(0.272)  
0.296 
(0.244)  
0.974 
(0.672)  
Hospital Focus 0.478 (0.484)   -  - 
Cardiac Department Focus - -0.433 *  
(0.254)   
- 
Process Focus - - -0.287 
(0.44) 
Log Hospital Volume  - 0.015 
(0.024) 
0.055 
(0.042) 
0.026 
(0.045) 
Log Cardiac Volume - -0.019 (0.05) 0.032 (0.043) 
R-Square 0.375 0.688 0.385 
N 467000 65454 18292 
Clusters 391 187 157 
Asymptotic Standard Errors in Parentheses * 10 % Statistical Significance, ** 5% Statistical Significance, *** 1 % 
Statistical Significance. Standard Errors are clustered at the hospital level. Patient level controls included age, 
gender, ZIP code household income, type of admission, DRG categorical variable, incidence of Myocardial Infarc-
tion, Congestive Heart Failure, Vascular Disease, COPD, Diabetes, Chronic Renal Failure, Hypertension, and the 
Charlson Index. The smaller number of patients reflects the fact that some of the zip codes were not available at the 
patient level for the IV estimation. This is because the zip codes for randomly chosen patients were masked out to 
protect their confidentiality. 
 
 
Table 6b: Effect of Level of Focus on Risk Adjusted Mortality Rate with Instrumental Variables 
 
Coefficient (1) (2) (3) 
Intercept  -2.46 *** 
(0.41)  
-2.31 *** 
(0.546)  
-1.46 * 
(0.79) 
Hospital Focus 0.696 
(0.685)  
 - - 
Cardiac Department Focus - 0.329 
(0.47)   
- 
Process Focus - - 0.319 
(1.34) 
Log Hospital Volume -0.048 (0.030) 0.117  * 
(0.065) 
-0.081 * 
(0.068) 
Log Cardiac Volume - -0.169 ** 
(0.073) 
-0.15 ** 
(0.07) 
Likelihood Ratio  
(Pr > Chi-Square) 
< 0.001 < 0.001 < 0.001 
N 455039 65288 18129 
Clusters 391 187 157 
Asymptotic Standard Errors in Parentheses * 10 % Statistical Significance, ** 5% Statistical Significance, *** 1 % 
Statistical Significance. Standard Errors are clustered at the hospital level. Patient level controls included age, 
gender, ZIP code household income, type of admission, DRG categorical variable, incidence of Myocardial Infarc-
tion, Congestive Heart Failure, Vascular Disease, COPD, Diabetes, Chronic Renal Failure, Hypertension, and the 
Charlson Index. The smaller number of patients reflects the fact that some of the zip codes were not available at the 
patient level for the IV estimation. This is because the zip codes for randomly chosen patients were masked out to 
protect their confidentiality. 
 
 
 
 33 
Appendix:  
Robustness Tests 
We performed several tests to examine the robustness of our findings.  We first performed a dis-
tance-based instrumental variables regression based on a median split of the patient population.  
Specifically, we first split the hospitals into focused and un-focused categories based on the me-
dian value for focus; only those hospitals with values for focus greater than the median were des-
ignated as focused hospitals. For each patient, we then calculate the differential distance, defined 
as the distance to the nearest focused hospital less the distance to the nearest hospital that can 
treat the patient.   We next use this differential distance as the instrumental variable to identify 
the effect of focus on outcome.   We perform these analyses for all three measures of focus; we 
find statistical significance for the effect of focus at the cardiac department level and process 
flow levels on reducing the length of stay.   In addition, we now find that hospital level focus is 
associated with a longer hospital stay for the randomly assigned patient.  This provides further 
evidence that the gains from hospital level focus are driven primarily by selective admissions.  
Second, although we account for various hospital level controls in our analysis, it is 
plausible that unobserved hospital level factors may bias our estimates for the effects of focus.  
To verify that such hospital level factors do not impact our results, we performed a longitudinal 
analysis of the effects of focus in which we include hospital fixed effects.  More specifically, we 
regressions we run are the form: 
 
where αh is the hospital fixed effect, and γt is the year dummy.  Xi is a vector of patient 
controls and η captures the effect of focus on outcome (Yiht) for patient i in hospital h in year t. 
To perform this regression, we collected additional data for the variables described in 
Section 5 for the years 1998 through 2006.   We examined the effect of focus on both length of 
stay and the likelihood of mortality for all three organizational levels of focus.  The results are 
summarized in Tables 11 and 12. We find that the coefficient for η is negative and similar for all 
cases, suggesting that hospital level confounding factors did not significantly impact our results.  
In the first stage IV regressions, we needed to determine the number of hospitals to in-
clude in the patient’s choice set.  We included hospitals as long as the regression coefficients 
were statistically significant at the 10% level.   In our analysis, we limited the number of hospit-
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als (K) in a patient’s choice set to the 15 nearest. As tests of robustness, we also include addi-
tional hospitals (corresponding to larger values of k).  However, we find that the inclusion of ad-
ditional hospitals does not significantly affect the patient’s choice, as evidenced by the statistical-
ly insignificant coefficient estimates for ρk.  The additional variables also had no impact on our 
estimators (focus).  This was to be expected because hospitals that are far away (say 15th in the 
patient’s choice set) have little impact on patient choice.   As expected, we find that the coeffi-
cient values for ρk are larger for smaller values of k in a stochastic sense, indicating that patients 
are more likely to end up at a focused hospital if they live in close proximity to one (Appendix 
Tables 7 and 8).  This provides evidence that our instrumental variable is relevant.   
The independence between the error term and the instrumental variable, also referred to 
as the exclusion restriction condition, is required for the validity of the instrumental variables. 
We verify the lack of strong statistical correlation between Focusik and the patient’s predicted 
risk of mortality, which is an observed measure of severity as evidence in support of the exclu-
sion restriction condition (Table 13). 
We performed the Hausman specification test to examine the endogeneity of the three fo-
cus measures.  We find that firm (hospital) Focus is endogenous (p = 0.0087). The F-statistic 
value from the first-stage regression for the IV estimator is statistically significant for the hospit-
al level focus indicating that our identification is strong.   However, the Hausman specification 
test does not reject the exogeneity of operating unit (Cardiac Department) Focus (p = 0.44) and 
Process Flow Focus (p = 0.80).  This confirms that patient selectivity based on unobserved fac-
tors is not significant in biasing our estimates for the effects of Cardiac Department Focus and 
Process Flow focus.  This finding also provides an explanation for the similarity of the IV and 
OLS estimates based for these two focus measures.  We also examine the exogeneity of the focus 
measures for estimating the effects on mortality using the Wald test.   We find that the exogenei-
ty is rejected at 0.108, 0.133, and 0.975 levels for the hospital level, operating unit level, and 
process levels respectively.   Thus, although we can reject endogeneity at the process level and 
operating unit levels (and hence rely on the probit results), we can only marginally reject endo-
geneity at the firm level.  
Finally, to test the robustness of the results for process flow focus, we split up the revas-
cularization patients based on the mean values of the pre-operative risk; the results are similar to 
those obtained with a median split. 
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Table 7: First Stage Estimates for the Effect of focus on Log (Risk Adjusted Length of Stay) 
  
Coefficient (1) (2) (3) 
Intercept 0.35389 0.084619 0.322618 
Focus0 0.180923 0.178841 0.069194 
Focus1 0.099249 0.133907 0.039594 
Focus2 0.08443 0.145081 0.029369 
Focus3 0.044693 0.161685 0.02893 
Focus4 0.012251 0.102908 0.020304 
Focus5 0.014997 0.099244 0.016689 
Focus6 - 0.079232 0.013614 
R-square 0.157 0.334 0.121 
Prob > F 0 0 0 
 All coefficients have statistical significance of 0.1 or better.  
 
Table 8: First Stage Estimates for the Effect of Focus on Risk Adjusted Mortality Rate 
Coefficient (1) (2) (3) 
Intercept 0.350845 0.079261 0.278161 
Focus0 0.176053 0.179538 0.066761 
Focus1 0.09848 0.133458 0.039313 
Focus2 0.080838 0.146689 0.029175 
Focus3 0.042867 0.162374 0.029046 
Focus4 0.012186 0.104394 0.020422 
Focus5 0.016108 0.100608 0.014973 
Focus6 - 0.080563 0.013768 
Prob > F 0 0 0 
 All coefficients have statistical significance of 0.1 or better.  
 
 
Table 9: Effect of Focus on Risk Adjusted Log (Length of Stay) with median split of IV 
 
Coefficient (1) (2) (3) 
Firm Focus 1.12 (0.68) * - - 
Operating Unit Focus - -1.36 (0.56) **  
Process Focus -  -1.74 (1.078) * 
R-Square 0.374 0.684 0.725 
Asymptotic Standard Errors in Parentheses * 10 % Statistical Significance, ** 5% Statistical Significance, *** 1 % 
Statistical Significance. Standard Errors are clustered at the hospital level.   Patient level controls included age, 
gender, ZIP code household income, type of admission, DRG categorical variable, incidence of Myocardial Infarc-
tion, Congestive Heart Failure, Vascular Disease, COPD, Diabetes, Chronic Renal Failure, Hypertension, and the 
Charlson Index. 
 
Table 10: Effect of Focus on Risk Adjusted Mortality Rate with median split of IV 
  
Coefficient (1) (2) (3) 
Firm Focus 0.475 (1.047) - - 
Operating Unit Focus - -1.50 (1.048)  
Process Focus -   3.19 (7.31) 
Likelihood Ratio  
(Pr > Chi-Square) 
< 0.001 < 0.001 < 0.001 
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Asymptotic Standard Errors in Parentheses * 10 % Statistical Significance, ** 5% Statistical Significance, *** 1 % 
Statistical Significance. Standard Errors are clustered at the hospital level. Patient level controls included age, 
gender, ZIP code household income, type of admission, DRG categorical variable, incidence of Myocardial Infarc-
tion, Congestive Heart Failure, Vascular Disease, COPD, Diabetes, Chronic Renal Failure, Hypertension, and the 
Charlson Index. 
 
 
Table 11: Effect of the Three Levels of Focus on Log (Length of Stay) with Hospital Fixed Effects 
Coefficient (1) (2) (3) 
Hospital Focus -0.482 *** 
(0.108) 
- - 
Cardiac Department Focus - -0.613*** 
(0.152) 
- 
Process Focus - - -0.099 
(0.075) 
Log Hospital Volume -0.0406 *** 
(0.016) 
-0.0346 
(0.0468) 
-0.0316 
(0.0307) 
Log Cardiac Volume - -0.000312 
(0.0388) 
0.0257 
(0.036) 
R-Square 0.3976 0.6735 0.4064 
Asymptotic Standard Errors in Parentheses * 10 % Statistical Significance, ** 5% Statistical Significance, *** 1 % 
Statistical Significance. Standard Errors are clustered at the hospital level.   Hospital Volume was included for all 
specifications and Cardiac department volume is included in all of the specifications except (1) because of colli-
nearity with the construct for department focus as department focus is explained by cardiac volume and total hos-
pital volume. Patient level controls included age, gender, ZIP code household income, type of admission, DRG cate-
gorical variable, incidence of Myocardial Infarction, Congestive Heart Failure, Vascular Disease, COPD, Di-
abetes, Chronic Renal Failure, Hypertension, and the Charlson Index. Estimates available from authors.  
 
 
Table 12: Effect of the Three Levels of Focus on Probit (Mortality) with Hospital Fixed Effects 
 
Coefficient (1) (2) (3) 
Hospital Focus -0.841 *** 
(0.227) 
- - 
Cardiac Department Focus - -0.332 **  
(0.159) 
- 
Process Focus - - -0.281 ***  
(0.115) 
Log Hospital Volume  0.105 
(0.64) 
0.066 
(0.073) 
Log Cardiac Volume  -0.15 *** 
(0.06) 
-0.159 ** 
(0.067) 
Likelihood Ratio  
(Pr > Chi-Square) 
< 0.001 < 0.001 < 0.001 
Asymptotic Standard Errors in Parentheses * 10 % Statistical Significance, ** 5% Statistical Significance, *** 1 % 
Statistical Significance. Standard Errors are clustered at the hospital level.   Hospital Volume was included for all 
specifications and Cardiac department volume is included in all of the specifications except (1) because of colli-
nearity with the construct for department focus as department focus is explained by cardiac volume and total hos-
pital volume. Patient level controls included age, gender, ZIP code household income, type of admission, DRG cate-
gorical variable, incidence of Myocardial Infarction, Congestive Heart Failure, Vascular Disease, COPD, Di-
abetes, Chronic Renal Failure, Hypertension, and the Charlson Index. Estimates available from authors.  
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Table 13:  Correlation between Predicted Mortality Rate and Instrumental Variables 
 
Coefficient Hospital Focus Cardiac Depart-
ment  
Process Flow Focus 
 Focus  
Estimate Standard 
Err 
Estimate Standard 
Err 
Estimate Standard 
Err 
Focus1 0.000395 0.000459 0.000951 0.000715 -0.00099 0.000654 
Focus2 -0.00049 0.000452 -0.00028 0.000633 -0.00131 0.000684 
Focus3 -0.00011 0.000457 0.001589 0.000699 0.000133 0.000547 
Focus4 -0.00046 0.000504 0.002157 0.000851 -0.00166 0.000618 
Focus5 -0.00018 0.000436 0.000633 0.0007 -0.00039 0.000588 
Focus6 0.000341 0.000481 0.003142 0.000825 -0.00025 0.000618 
Focus7 -0.00044 0.000451 0.001183 0.000826 -0.00038 0.000651 
Focus8 -0.00084 0.000491 0.000379 0.000817 0.000664 0.000592 
Focus9 0.000308 0.000523 -0.00023 0.000819 0.000503 0.000693 
Focus10 -0.00057 0.00053 0.000628 0.000756 0.000791 0.000657 
Focus11 -9.9E-05 0.000492 -0.00014 0.000643 -0.00105 0.000568 
Focus12 0.000573 0.000505 -0.00043 0.000788 -0.00015 0.000539 
Focus13 5.96E-05 0.000487 0.001025 0.000616 -0.00077 0.000647 
Focus14 -1.8E-05 0.00046 0.000455 0.000636 0.000469 0.000505 
Focus15 0.000232 0.000463 0.000875 0.000763 -0.0001 0.000691 
 
 
 
Table 14: Effect on LOS for the subset of 18,797 patients undergoing a CABG 
 
 
Model 1 
 
Model 2 
 
Model 3 
 
Model 4 
 
Model 5 
 
Variable Estimate Std Err Estimate Std Err Estimate Std Err Estimate Std Err Estimate Std Err 
1-17 years baseline 
         
18-34 Years -0.0880 0.3075 -0.0758 0.3140 -0.1092 0.3042 -0.0832 0.3065 -0.0967 0.3106 
35 - 65 Years 0.1010 0.3002 0.1156 0.3067 0.0804 0.2976 0.1054 0.3009 0.0951 0.3057 
65 Years or greater 0.2013 0.3004 0.2159 0.3069 0.1806 0.2978 0.2059 0.3010 0.1956 0.3058 
Male -0.0653 0.0160 -0.0676 0.0161 -0.0627 0.0155 -0.0645 0.0148 -0.0618 0.0133 
Admission Unscheduled 0.6158 0.0358 0.6207 0.0366 0.6219 0.0370 0.6172 0.0400 0.6320 0.0420 
Current Myocardial Infarction 0.0306 0.0140 0.0319 0.0139 0.0297 0.0140 0.0304 0.0135 0.0298 0.0133 
Old Myocardial Infarction -0.1276 0.0335 -0.1263 0.0337 -0.1276 0.0336 -0.1276 0.0334 -0.1266 0.0335 
Congestive Heart Failure 0.1999 0.0137 0.1995 0.0138 0.2012 0.0142 0.2000 0.0138 0.2016 0.0143 
Peripheral Vascular Disease Diagnosed -0.1030 0.0342 -0.1020 0.0342 -0.1024 0.0342 -0.1031 0.0341 -0.1012 0.0341 
Peripheral Vascular Disease Surgery 0.0876 0.0710 0.0892 0.0705 0.0861 0.0716 0.0876 0.0709 0.0867 0.0714 
Cerebrovascular Disease 0.1463 0.0167 0.1456 0.0166 0.1458 0.0170 0.1463 0.0168 0.1449 0.0169 
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COPD -0.0242 0.0295 -0.0231 0.0296 -0.0256 0.0295 -0.0239 0.0297 -0.0248 0.0298 
Diabetes -0.0924 0.0283 -0.0917 0.0282 -0.0914 0.0283 -0.0921 0.0283 -0.0896 0.0282 
Diabetes with Sequelae -0.1271 0.0572 -0.1252 0.0572 -0.1268 0.0573 -0.1270 0.0572 -0.1246 0.0572 
Chronic Renal Failure 0.0047 0.0624 0.0073 0.0627 0.0043 0.0625 0.0047 0.0623 0.0061 0.0624 
Hypertension -0.0683 0.0115 -0.0673 0.0116 -0.0675 0.0111 -0.0686 0.0111 -0.0672 0.0108 
Charlson Risk Score 0.1151 0.0297 0.1142 0.0297 0.1149 0.0297 0.1150 0.0298 0.1137 0.0297 
Log Hospital Volume 0.0324 0.0403 0.0475 0.0331 0.0538 0.0440 0.0328 0.0409 0.0455 0.0322 
Log Cardiac Volume 0.0268 0.0370 - - 0.0051 0.0442 0.0265 0.0370 - - 
Hospital Focus 
  
-0.0169 0.2104 
    
-0.1575 0.2289 
Cardiac Department Focus 
    
0.1688 0.4105 
  
0.2301 0.1337 
Process Focus 
      
0.0230 0.1384 0.055243 0.13396 
Intercept 1.6896 0.4155 1.7366 0.4360 1.6600 0.4105 1.6653 0.4532 1.739039 0.456901 
R-square 0.3869 
 
0.3898 
 
0.3877 
 
0.3870 
 
0.3882 
 
 
           
 
Table 15: Effect on Mortality for the subset of 18,797 patients undergoing a CABG 
 
          
 
Model 1 
 
Model 2 
 
Model 3 
 
Model 4 
 
Model 5 
 
Variable Estimate Std Err Estimate Std Err Estimate Std Err Estimate Std Err Estimate Std Err 
18-34 -0.339 0.438 -0.339 0.438 -0.348 0.441 -0.316 0.440 -0.328 0.444 
35-65 -0.315 0.054 -0.314 0.054 -0.316 0.054 -0.314 0.054 -0.314 0.054 
65 and above baseline 
         
Male -0.181 0.046 -0.181 0.046 -0.180 0.046 -0.181 0.047 -0.181 0.046 
Unscheduled (baseline missing) -0.276 0.602 -0.273 0.606 -0.268 0.601 -0.305 0.583 -0.294 0.582 
Current Myocardial Infarction 0.131 0.055 0.130 0.055 0.132 0.055 0.139 0.055 0.142 0.054 
Old Myocardial Infarction -0.599 0.120 -0.599 0.120 -0.599 0.119 -0.601 0.119 -0.601 0.118 
Congestive Heart Failure 0.158 0.044 0.158 0.043 0.157 0.043 0.157 0.043 0.154 0.043 
Peripheral Vascular Disease Diagnosed -0.164 0.113 -0.163 0.113 -0.166 0.113 -0.161 0.112 -0.162 0.112 
Peripheral Vascular Disease Surgery 0.345 0.216 0.343 0.216 0.348 0.214 0.344 0.216 0.347 0.213 
Cerebrovascular Disease 0.083 0.066 0.082 0.066 0.084 0.066 0.085 0.066 0.088 0.066 
COPD -0.411 0.110 -0.412 0.110 -0.410 0.109 -0.416 0.110 -0.416 0.109 
Diabetes -0.554 0.107 -0.554 0.107 -0.558 0.107 -0.557 0.106 -0.562 0.106 
Diabetes with Sequelae -1.158 0.215 -1.158 0.215 -1.160 0.216 -1.163 0.214 -1.166 0.215 
Chronic Renal Failure -0.446 0.196 -0.449 0.196 -0.447 0.195 -0.442 0.197 -0.446 0.195 
Hypertension -0.295 0.050 -0.297 0.050 -0.297 0.049 -0.292 0.049 -0.295 0.049 
Charlson Risk Score 0.390 0.092 0.390 0.092 0.391 0.092 0.392 0.092 0.394 0.092 
Log Hospital Volume 0.102 0.073 -0.065 0.059 0.070 0.077 0.085 0.070 -0.066 0.056 
Log Cardiac Volume -0.164 0.070 - - -0.130 0.076 -0.151 0.069 - - 
Hospital Focus 
  
-0.722 0.330 
    
-0.442 0.335 
Cardiac Department Focus 
  
- - -0.260 0.212 
  
-0.384 0.192 
Process Focus 
  
- - 
  
-0.564 0.185 -0.622 0.181 
Intercept -1.788 0.817 -1.337 0.856 -1.688 0.811 -1.524 0.815 -1.067 0.855 
(Pr > Chi-Square) 0.000 
 
0.000 
 
0.000 
 
0.000 
 
0.000 
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Table 16a: Effect of Level of Focus on Log (Risk Adjusted Length of Stay) with Instrumental Va-
riables for CABG Patients Only 
 
Coefficient (1) (2) (3) 
Intercept  2.178 *** 
(0.85)  
1.099 
(0.744)  
0.974 
(0.672)  
Hospital Focus -1.18 (1.477)  -  - 
Cardiac Department Focus - -0.581   
(0.680)   
- 
Process Focus - - -0.287 
(0.44) 
Log Hospital Volume  - 0.062 
(0.056) 
- 0.042 
(0.094) 
0.026 
(0.045) 
Log Cardiac Volume - 0.10 (0.09) 0.032 (0.043) 
R-Square 0.367 0.372 0.385 
N 18292 18292 18292 
Clusters 157 157 157 
Asymptotic Standard Errors in Parentheses * 10 % Statistical Significance, ** 5% Statistical Significance, *** 1 % Statistical 
Significance. Standard Errors are clustered at the hospital level. Patient level controls included age, gender, ZIP code household 
income, type of admission, DRG categorical variable, incidence of Myocardial Infarction, incidence of PCI, Congestive Heart 
Failure, Vascular Disease, COPD, Diabetes, Chronic Renal Failure, Hypertension, and the Charlson Index. The smaller number 
of patients reflects the fact that some of the zip codes were not available at the patient level for the IV estimation. This is because 
the zip codes for randomly chosen patients were masked out to protect their confidentiality. 
 
 
Table 16b: Effect of Level of Focus on Risk Adjusted Mortality Rate with Instrumental Variables 
for CABG Patients Only 
 
Coefficient (1) (2) (3) 
Intercept  -0.879  
(1.589)  
-1.94 ** 
(0.953)  
-1.46 * 
(0.79) 
Hospital Focus -1.069 
(1.23)  
 - - 
Cardiac Department Focus - 0.530 
(1.07)   
- 
Process Focus - - 0.319 
(1.34) 
Log Hospital Volume -0.102 (0.127) 0.163  
(0.14) 
-0.081 * 
(0.068) 
Log Cardiac Volume - -0.23 * 
(0.14) 
-0.15 ** 
(0.07) 
Likelihood Ratio  
(Pr > Chi-Square) 
< 0.001 < 0.001 < 0.001 
N 18292 18292 18129 
Clusters 157 157 157 
Asymptotic Standard Errors in Parentheses * 10 % Statistical Significance, ** 5% Statistical Significance, *** 1 % Statistical 
Significance. Standard Errors are clustered at the hospital level. Patient level controls included age, gender, ZIP code household 
income, type of admission, DRG categorical variable, incidence of Myocardial Infarction, incidence of PCI, Congestive Heart 
Failure, Vascular Disease, COPD, Diabetes, Chronic Renal Failure, Hypertension, and the Charlson Index. The smaller number 
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of patients reflects the fact that some of the zip codes were not available at the patient level for the IV estimation. This is because 
the zip codes for randomly chosen patients were masked out to protect their confidentiality. 
 
 
 
 
